Co-Infections in Critically Ill Patients with or without COVID-19: A Comparison of Clinical Microbial Culture Findings.
COVID-19
SARS-CoV-2
antimicrobial consumption
antimicrobial expenditure
co-infection
intensive care unit
microbial culture
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
20 04 2021
20 04 2021
Historique:
received:
01
03
2021
revised:
12
04
2021
accepted:
15
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
6
5
2021
Statut:
epublish
Résumé
Co-infections in critically ill patients hospitalized for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have an important impact on the outcome of coronavirus disease 2019 (COVID-19). We compared the microbial isolations found in COVID-19 patients hospitalized in an intensive care unit (ICU) with those in a non-COVID-19 ICU from 22 February to 30 April 2020 and in the same period of 2019. We considered blood, urine or respiratory specimens obtained with bronchoalveolar lavage (BAL) or bronchial aspirate (BASP), collected from all patients admitted in ICUs with or without COVID-19 infection. We found a higher frequency of infections due to methicillin-resistant (MR) staphylococci, vancomycin-resistant
Identifiants
pubmed: 33923992
pii: ijerph18084358
doi: 10.3390/ijerph18084358
pmc: PMC8073702
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Herz. 2020 Jun;45(4):329-331
pubmed: 32313971
Clin Infect Dis. 2010 Mar 1;50(5):625-63
pubmed: 20175247
Mycoses. 2021 Feb;64(2):152-156
pubmed: 33275821
Open Forum Infect Dis. 2020 Jun 05;7(6):ofaa220
pubmed: 32613024
Clin Microbiol Infect. 2021 Mar;27(3):451-457
pubmed: 33223114
Front Microbiol. 2017 Jun 23;8:1041
pubmed: 28690590
Emerg Microbes Infect. 2020 Dec;9(1):1958-1964
pubmed: 32815458
Mycopathologia. 2020 Aug;185(4):607-611
pubmed: 32737746
J Antimicrob Chemother. 2020 Nov 1;75(11):3386-3390
pubmed: 32766706
Clin Microbiol Infect. 2020 Oct;26(10):1395-1399
pubmed: 32603803
J Hosp Infect. 2021 Jan;107:95-97
pubmed: 33217490
Clin Infect Dis. 2005 Feb 15;40(4):633-4; author reply 634-5
pubmed: 15712093
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S81-7
pubmed: 20597676
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Acta Biomed. 2020 Sep 07;91(3):e2020017
pubmed: 32921713
Clin Microbiol Infect. 2012 Sep;18(9):E355-61
pubmed: 22784359
Clin Infect Dis. 2020 Jul 28;71(15):769-777
pubmed: 32176772
JAMA. 2020 May 26;323(20):2052-2059
pubmed: 32320003
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1380-1388
pubmed: 32275452
Autoimmun Rev. 2020 Jul;19(7):102567
pubmed: 32376392
Antibiotics (Basel). 2020 Nov 17;9(11):
pubmed: 33212785
J Infect. 2020 Aug;81(2):266-275
pubmed: 32473235
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
Farm Hosp. 2012 Jan-Feb;36(1):33.e1-30
pubmed: 22137161
Lancet Infect Dis. 2013 Sep;13(9):752-61
pubmed: 23891402
Pediatr Pulmonol. 2020 May;55(5):1169-1174
pubmed: 32134205
J Infect. 2021 Feb;82(2):e45-e46
pubmed: 32771402
Int J Antimicrob Agents. 2011 Dec;38 Suppl:64-70
pubmed: 22018988
Clin Infect Dis. 2004 Aug 15;39(4):511-6
pubmed: 15356814
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Ann Am Thorac Soc. 2020 Jul;17(7):839-846
pubmed: 32255382
J Heart Lung Transplant. 2020 May;39(5):405-407
pubmed: 32362390
Infect Dis Ther. 2020 Sep;9(3):417-420
pubmed: 32474891
Eur Urol. 2015 Mar;67(3):546-58
pubmed: 25477258
J Med Virol. 2020 Jul;92(7):797-806
pubmed: 32198776